Theresa McNeely

Bio:

Theresa McNeely has more than 25 years of integrated corporate communications experience spanning investor relations, public relations, marketing communications and patient advocacy in life sciences companies, including pharmaceutical, biotech, diagnostics and medical device firms. 

Ms. McNeely was most recently Chief Communications Officer & Patient Advocate at Homology Medicines where she led investor relations, public relations, and interactions with patient advocacy groups and key opinion leaders.  Prior to Homology, she was SVP, Investor Relations and Corporate Communications at Akebia Therapeutics, and before that she was EVP, Chief Communications Officer at OvaScience. She also held management positions at a number of other companies including Millennium Pharmaceuticals, EXACT Sciences, Clinical Data, Inc. and Pyrosequencing. Earlier in her career, Ms. McNeely worked on Wall Street for a boutique investment bank as a stockbroker and supported a portfolio manager and analyst. Ms. McNeely is a member of the National Board of Directors for Women in Bio and an Advisory Board member for Cramer Productions — a creative brand experience agency, and currently serves as their lead director for the Cramer Health division. 

Ms. McNeely received her B.S. in Business Management from Providence College, and an M.S. in Business Communications and Healthcare Communications from Simmons College.